Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +33.64%
#3 Cysic Cysic +15.00%
#4 Fabric Protocol Fabric Protocol +9.87%
#5 Perle Perle +8.90%
#6 Bedrock Bedrock +8.53%
#7 Biconomy Biconomy +4.22%
#8 The Black Bull The Black Bull +3.95%
#9 Cap Cap +3.80%
#10 BOOK OF MEME BOOK OF MEME +3.69%
Coin of the day
EXOD EXOD
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Idogen AB (publ) Idogen AB (publ)

Idogen AB (publ)

IDOGEN
Rang in aandelen #37811
Idogen AB (publ) is a Swedish biotechnology company specializing in the... Idogen AB (publ) is a Swedish biotechnology company specializing in the development of tolerogenic cell therapies. These innovative treatments are engineered to prevent a patient's immune system from attacking crucial elements, including biological agents, transplanted organs, and the body's own cells or tissues. The company's most advanced product in development is IDO 8, designed for individuals with severe haemophilia A who have developed neutralizing antibodies against their vital coagulation factor VIII treatment. Idogen is also developing IDO T, a tolerogenic cell therapy intended to prevent organ transplant rejection, primarily for kidney transplants, and IDO AID, aimed at treating autoimmune diseases. Established in 2008, the company is headquartered in Lund, Sweden.
Aandeelprijs
$0.01345907
Laatst gesynchroniseerd: 2024-07-12
Marktkapitalisatie
$1.43M
Verandering (1 dag)
22.16%
Verandering (1 jaar)
0.00%
Land
SE
Handel Idogen AB (publ) (IDOGEN)

Categorie

Healthcare
Aandelsplitsingen voor Idogen AB (publ) (IDOGEN)
Het aandeel Idogen AB (publ) (symbool: IDOGEN) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 15, 2026.
Eén aandeel IDOGEN dat vóór Aug 15, 2026 werd gekocht, staat nu gelijk aan 0 aandelen IDOGEN.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE